Literature DB >> 12456957

The role of activin a in regulation of hemopoiesis.

Yaron Shav-Tal1, Dov Zipori.   

Abstract

Activin A, a cytokine member of the transforming growth factor-beta superfamily, is expressed locally by the mesenchymal component of the hemopoietic microenvironment. Its expression is regulated on the mRNA level by different cytokines, and the biological activity of the protein is tightly controlled by several inhibitory molecules. Activin A affects hemopoietic cells of various lineages, as evidenced by in vitro studies of leukemia and lymphoma cell lines, which were used to elucidate the mechanism of its action. In the B-cell lineage, activin A is a cell cycle inhibitor, a mediator of apoptosis, and a cytokine antagonist. Limited information is available on the effects of activin A on normal hemopoietic cells. Recent studies suggest that it might be a negative regulator of normal B lymphopoiesis. Whereas the functions of activin A in vitro are well established, further research tools are needed to elucidate its role within specific hemopoietic microenvironments in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456957     DOI: 10.1634/stemcells.20-6-493

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  19 in total

1.  FOXO3 modulates endothelial gene expression and function by classical and alternative mechanisms.

Authors:  Tobias Czymai; Dorothee Viemann; Carsten Sticht; Grietje Molema; Matthias Goebeler; Marc Schmidt
Journal:  J Biol Chem       Date:  2010-02-01       Impact factor: 5.157

2.  Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia.

Authors:  Rajasekhar N V S Suragani; Sharon M Cawley; Robert Li; Samantha Wallner; Mark J Alexander; Aaron W Mulivor; Sara Gardenghi; Stefano Rivella; Asya V Grinberg; R Scott Pearsall; Ravindra Kumar
Journal:  Blood       Date:  2014-05-02       Impact factor: 22.113

3.  Testes-specific protease 50 promotes cell proliferation via inhibiting activin signaling.

Authors:  Z-B Song; P Wu; J-S Ni; T Liu; C Fan; Y-L Bao; Y Wu; L-G Sun; C-L Yu; Y-X Huang; Y-X Li
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

4.  Activin A promotes hematopoietic fated mesoderm development through upregulation of brachyury in human embryonic stem cells.

Authors:  Chantal Cerdan; Brendan A S McIntyre; Rami Mechael; Marilyne Levadoux-Martin; Jiabi Yang; Jung Bok Lee; Mickie Bhatia
Journal:  Stem Cells Dev       Date:  2012-06-13       Impact factor: 3.272

Review 5.  The role of TGFβ in hematopoiesis and myeloid disorders.

Authors:  Alex Bataller; Guillermo Montalban-Bravo; Kelly A Soltysiak; Guillermo Garcia-Manero
Journal:  Leukemia       Date:  2019-02-28       Impact factor: 11.528

6.  The use of luspatercept for thalassemia in adults.

Authors:  Maria Domenica Cappellini; Ali T Taher
Journal:  Blood Adv       Date:  2021-01-12

7.  Effects of miR‑210‑3p on the erythroid differentiation of K562 cells under hypoxia.

Authors:  Caiyan Hu; Yupeng Yan; Chengbing Fu; Jin Ding; Tiantian Li; Shuqiong Wang; Liu Fang
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

8.  Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer.

Authors:  H Kaneda; T Arao; K Matsumoto; M A De Velasco; D Tamura; K Aomatsu; K Kudo; K Sakai; T Nagai; Y Fujita; K Tanaka; K Yanagihara; Y Yamada; I Okamoto; K Nakagawa; K Nishio
Journal:  Br J Cancer       Date:  2011-09-06       Impact factor: 7.640

9.  Gene expression in primate liver during viral hemorrhagic fever.

Authors:  Mahmoud Djavani; Oswald R Crasta; Yan Zhang; Juan Carlos Zapata; Bruno Sobral; Melissa G Lechner; Joseph Bryant; Harry Davis; Maria S Salvato
Journal:  Virol J       Date:  2009-02-12       Impact factor: 4.099

10.  Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis.

Authors:  Rajasekhar N V S Suragani; Samuel M Cadena; Sharon M Cawley; Dianne Sako; Dianne Mitchell; Robert Li; Monique V Davies; Mark J Alexander; Matthew Devine; Kenneth S Loveday; Kathryn W Underwood; Asya V Grinberg; John D Quisel; Rajesh Chopra; R Scott Pearsall; Jasbir Seehra; Ravindra Kumar
Journal:  Nat Med       Date:  2014-03-23       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.